Phorbol ester inhibits DNA damage-induced apoptosis in U937 cells through activation of protein kinase C

Life Sciences

Volumn 65, Issue 21, 1999, Pages 2251-2258

  Kaneko, Yoko S ^a,c   Ikeda, Kyoji ^a   Nakanishi, Makoto ^a,b  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1,25(OH)2D3; 4 PDD; Apoptosis; db cAMP; PKC; PMA; U937 cells

Indexed keywords

4ALPHA PHORBOL DIDECANOATE; CALPHOSTIN C; COLECALCIFEROL; COLECALCIFEROL DERIVATIVE; CYCLIC AMP; DNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PROMYELOCYTIC LEUKEMIA; ULTRAVIOLET IRRADIATION;

APOPTOSIS; BLOTTING, NORTHERN; BUCLADESINE; CALCITRIOL; CELL DIFFERENTIATION; DNA DAMAGE; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; NAPHTHALENES; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE; U937 CELLS; ULTRAVIOLET RAYS;

EID: 0033569337     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00490-7     Document Type: Article

References (20)

1. J.F.R. Kerr, A.H. Wyllie and A.R. Currie, Br. J. Cancer 26 239-257 (1972).
2. L.D. Tomei, P. Kanter and C.E. Wenner, Biochem. Biophys. Res. Commun. 155 324-331 (1988).
3. D.J. McConkey, S. Orrenius and M. Jondal, Immunol. Today 11, 120-121 (1990).
4. L.E. Benhamou, P.A. Cazenave and P. Sarthou, Eur. J. Immunol. 20 1405-1407 (1990).
5. M. Perotti, F. Toddei, F. Mirabelli, M. Vairetti, G. Bellomo, D.J. McConkey and S. Orrenius, FEBS Lett. 259 331-334 (1990).
6. M.A. Valentine and K.A. Licciardi, Eur. J. Immunol. 22 3141-3148 (1992).
7. G.T. Williams and C.A. Smith, Cell 74 777-779 (1993).
8. L.E. Gerschenson and R.J. Rotello, FASEB J. 6 2450-2455 (1992).
9. W.D. Jarvis, F.A. Fornari, J.J. Browning, D.A. Gewirtz, R.N. Kolesnick and S. Grant, J. Biol. Chem. 269 31685-31692 (1994).
10. M. Iwata, R. Iseki, K. Sato, Y. Tozawa and Y. Ohoka, Int. Immunol. 6 431-438 (1994).
11. Y. Azuma, Y. Onishi, Y. Sato and H. Kizaki, Cell Immun. 152 271-278 (1993).
12. E. Gulbins, K.M. Coggeshall, G. Baier, D. Telford, C. Langlet, G. Baier-Bitterlich, N. Bonnefoy-Berard, P. Burn, A. Wittinghofer and A. Altman, Mol. Cell. Biol. 14 4749-4758 (1994).
13. J. Lotem and L. Sachs, Proc. Natl. Acad. Sci. USA 76 5158-5162 (1979).
14. C. Miyaura, E. Abe, T. Kuribayashi, H. Tanaka, K. Konno, Y. Nishii and T. Suda, Biochem, Biophys. Res. Commun. 132 223-231 (1981).
15. H. Tanaka, E. Abe, C. Miyaura, Y. Shiina and T. Suda, Biochem, Biophys. Res. Commun. 117 86-92 (1983).
16. Y.X. Zeng and W.S. El-Deily, Oncogene 12 1557-1564 (1996).
17. J. Wang and K. Walsh, Science 273 359-361 (1996).
18. Y. Lu, N. Yamaguchi, T. Yagi and H. Takebe, Oncogene 16 705-712 (1998).
19. L.Y. Romanova, I.A. Alexandrov, G. Schwab, D.M. Hilbert, J.F. Muchinski and R.P. Nordan, Biochemistry 25 9900-9906 (1996).
20. S. Wang, J.A. Vrana, T.M. Bartimole, A.J. Freemerman, W.D. Jarvis, L.B. Kramer, G. Krystal, P. Dent and S. Grant, Mol. Pharmacol. 52 1000-1009 (1997).